002262 恩华药业
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额280,4081,078,390916,1271,008,300861,023
投资活动产生之现金流量净额(84,845)(561,937)(1,411,478)(293,391)(688,902)
筹资活动产生之现金流量净额(413,033)(386,098)(300,971)(210,174)(240,779)
汇率变动对现金及现金等价物的影响4,546(1,036)171415908
现金及现金等价物净增加/(减少)(212,923)129,319(796,151)505,150(67,750)
期初现金及现金等价物余额1,342,7821,213,4622,009,6131,504,4631,572,212
期末现金及现金等价物余额1,129,8581,342,7821,213,4622,009,6131,504,463